De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

BrainCool Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jon Berg

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	4.8yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	4.8yrs
Gemiddelde ambtstermijn bestuur	less than a year

Recente managementupdates

Recent updates

How Much Did BrainCool's(NGM:BRAIN) Shareholders Earn From Share Price Movements Over The Last Five Years?

Jan 14

CEO

Jon Berg

4.8yrs

Tenure

Mr. Jon Berg serves as Chief Operating Officer at BrainCool AB (publ) from 2020 and serves as its Chief Executive Officer from February 2024 and served as its Development & Quality Assurance Manager. Mr. B...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Jon Berg	CEO & COO	4.8yrs	geen gegevens	geen gegevens
Lotta Valfridsson	Chief Financial Officer	1.8yrs	geen gegevens	0.049% SEK 226.4k
Thomas Falk	Chief Technology Officer	5.8yrs	geen gegevens	geen gegevens
Christian Strand	Head of Distribution & Sales	less than a year	geen gegevens	geen gegevens
Oscar Engellau	Executive Director	no data	geen gegevens	geen gegevens
Mohammad Fazel	Head of Clinical Studies	6.8yrs	geen gegevens	geen gegevens

4.8yrs

Gemiddelde duur

Ervaren management: Het managementteam van BRAIN wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Oscar Engellau	Executive Director	1.8yrs	geen gegevens	geen gegevens
Hans Henriksson	Chairman of the Board	10.8yrs	geen gegevens	geen gegevens
Jens Lindberg	Independent Director	less than a year	geen gegevens	geen gegevens
Klaus Bratlie	Independent Director	less than a year	geen gegevens	geen gegevens
Michelle Hessius	Independent Director	less than a year	geen gegevens	geen gegevens

0.3yrs

Gemiddelde duur

53yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van BRAIN wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.3 jaar), wat duidt op een nieuw bestuur.

BrainCool Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Braincool AB (Publ) Approves Board Appointments

BrainCool AB (publ) Announces Roger Henriksson Declines Re-Election as Board Member

CEO & Director recently sold kr254k worth of stock

CEO & Director recently bought kr53k worth of stock

CEO & Director recently bought kr62k worth of stock

No independent directors

Recent updates

Second quarter 2024 earnings released

Braincool AB (Publ) Approves Board Appointments

BrainCool AB (publ) Announces Roger Henriksson Declines Re-Election as Board Member

BrainCool AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 85.763172 million.

BrainCool AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 85.763172 million.

BrainCool AB (publ) to Report Fiscal Year 2024 Results on Feb 10, 2025

Full year 2023 earnings released

Braincool AB (Publ) Announces Karolinska Starts the Clinical Study PRINCESS 2 with BrainCool's Product RhinoChill® System

New major risk - Share price stability

BrainCool AB (publ) and University of Freiburg Announces Start of Pivotal Clinical Trial (Cottis 2) for Combined Target Temperature Management and Thrombectomy After Ischemic Stroke

CEO & Director recently sold kr254k worth of stock

Third quarter 2023 earnings released

Braincool AB (Publ) Announces New Clinical Study Evaluating Early Hypothermia Treatment After Cardiac Arrest with the Braincool System and Rhinochill System

CEO & Director recently bought kr53k worth of stock

American Medical Association Approves New Current Procedural Terminology Code for Cryotherapy Using BrainCool's Cooral System

BrainCool AB (publ) Announces New CPT Code from AMA for Cooral® System supports Pathway to Reimbursement in the U.S

CEO & Director recently bought kr62k worth of stock

Second quarter 2023 earnings released

New major risk - Share price stability

Braincool AB (Publ) Introduces Minichill in Japan

Braincool AB (Publ) Announces New Patent Application for Rhinochill Technology Paves the Way for New Possibilities

BrainCool AB (publ) Receives Patent Approval for "Shivering" in the EU for the Product BrainCool System

Braincool AB (Publ) Announces International Clinical Study with Rhinochill®System of Patients with Sudden Cardiac Arrest Obtain Ethical Approval

First quarter 2023 earnings released

BrainCool AB (publ) to Report Q3, 2023 Results on Nov 30, 2023

BraincCool Launches New Commercialization Strategy for Its Breakthrough Product Cooral ®System Aiming for Reimbursement in the U.S

Is BrainCool (NGM:BRAIN) In A Good Position To Invest In Growth?

BrainCool AB (publ) to Report Fiscal Year 2022 Results on Feb 28, 2023

Third quarter 2022 earnings released: kr0.17 loss per share (vs kr0.12 loss in 3Q 2021)

Here's Why BrainCool (NGM:BRAIN) Can Afford Some Debt

No independent directors

BrainCool AB (publ) to Report Q3, 2022 Results on Nov 30, 2022

BrainCool AB (publ) Announces FDA approval of Cooral

Second quarter 2022 earnings released: kr0.18 loss per share (vs kr0.13 loss in 2Q 2021)

We Think BrainCool (NGM:BRAIN) Has A Fair Chunk Of Debt

First quarter 2022 earnings released: kr0.14 loss per share (vs kr0.12 loss in 1Q 2021)

BrainCool AB (publ) to Report Q1, 2022 Results on May 31, 2022

No independent directors

CEO & Director recently bought kr73k worth of stock

CEO & Director recently bought kr195k worth of stock

CEO & Director recently bought kr195k worth of stock

CEO & Director recently bought kr195k worth of stock

Is BrainCool (NGM:BRAIN) A Risky Investment?

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2021 earnings released: kr0.13 loss per share (vs kr0.15 loss in 2Q 2020)

CEO & Director recently bought kr238k worth of stock

BrainCool AB (publ), Annual General Meeting, Apr 15, 2021

Full year 2020 earnings released: kr0.68 loss per share (vs kr1.43 loss in FY 2019)

BrainCool AB (publ) Receives FDA "Breakthrough Device" Designation for Cooral® System for Prevention of Oral Mucositis

New 90-day high: kr9.17

How Much Did BrainCool's(NGM:BRAIN) Shareholders Earn From Share Price Movements Over The Last Five Years?

Third quarter 2020 earnings released: kr0.12 loss per share

New 90-day low: kr7.00

Braincool AB Announces Statistically Significant Late-Breaking Clinical Data At SMO Virtual Congress 2020

New 90-day high - kr11.24

BrainCool AB (publ) to Report Q2, 2020 Results on Aug 28, 2020

New 90-day high - kr7.15

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd